Der Daten-Goldrausch in der Onkologie: Das Kapital sind die Patientendaten
In 2025 pharma majors moved from buying AI to building it on someone else's data. Tempus and ConcertAI showed the asset in oncology AI is the patient data.
Mehr lesen
In 2025 pharma majors moved from buying AI to building it on someone else's data. Tempus and ConcertAI showed the asset in oncology AI is the patient data.
Mehr lesen